Showing results (581-590 of 759) with videos related to
Sort By:
Pageof 76
The Journal of Allergy and Clinical Immunology|August 10, 2025
Effect of dupilumab on small airways measured by airway oscillometry in VESTIGEGeorge R Washko, Brian J Lipworth, Dinesh Saralaya, et al.Blood Pressure|March 13, 2024
Visit-to-visit blood pressure variability and progression of white matter hyperintensities over 14 yearsEsther Janssen, Jan Willem van Dalen, Mengfei Cai, et al.The Journal of Allergy and Clinical Immunology. in Practice|June 15, 2024
Type 2 Inflammation and Asthma in Children: A Narrative ReviewNikolaos G Papadopoulos, Leonard B Bacharier, Daniel J Jackson, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1993
EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2R Khanna, S R Burrows, A Suhrbier, et al.Plos One|January 16, 2015
The diagnostic value of clinical symptoms in women and men presenting with chest pain at the emergency department, a prospective cohort studyManon G van der Meer, Barbra E Backus, Yolanda van der Graaf, et al.Pediatric Pulmonology|July 17, 2024
Dupilumab 200 mg was efficacious in children (6-11 years) with moderate-to-severe asthma for up to 2 years: EXCURSION open-label extension studyWanda Phipatanakul, Christian Vogelberg, Leonard B Bacharier, et al.Indian Journal of Cancer|December 5, 2017
Dual mutations and complex mutations in metastatic nonsmall cell lung cancer: A single-institution experience from South IndiaL Kadabur, D Koppaka, G B Kanakasetty, et al.Human Reproduction (Oxford, England)|December 21, 2016
Stability of the human sperm DNA methylome to folic acid fortification and short-term supplementationD Chan, S McGraw, K Klein, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 6, 2023
Dupilumab long-term efficacy in patients with non-OCS-dependent asthma with and without evidence of allergic asthmaLawrence D Sher, Jonathan Corren, Ian D Pavord, et al.ERJ Open Research|December 17, 2024
Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristicsMichael E Wechsler, Linda Rogers, G Walter Canonica, et al.Pageof 76